Jack Smith India Private Limited

Jack Smith India Private Limited

Pharmaceutical company with diverse product portfolio, established in 2021.
2021 | Kamrup, Assam (India) | Active

Last Updated:

December 23, 2024
HomeCompanyJack Smith India Private Limited

Who are the key members and board of directors at Jack Smith India?

Board Members(2)

NameDesignationAppointment DateStatus
Pintu Mehta In Director 07-Jul-2021Current
Guddu Jha In Director 07-Jul-2021Current

Financial Performance of Jack Smith India.

Jack Smith India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 724.26% increase. The company also saw a substantial improvement in profitability, with a 297.64% increase in profit. The company's net worth Soared by an impressive increase of 134.72%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
724.26%
Revenue from Operations
723.93%
Total Assets
221.58%
Profit or Loss
297.64%
Net Worth
134.72%
EBITDA
320.56%

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹1.00 M

LenderAmountStatus

Others

Creation Date: 31 Oct 2023
₹1.00 MOpen

How Many Employees Work at Jack Smith India?

Jack Smith India has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Jack Smith India

Recent activity within the organization

  • Annual General Meeting

    Jack Smith India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Jack Smith India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Shillong.

    31 Mar 2024

  • Charges

    A charge with Others amounted to Rs. 1.00 M with Charge ID 100868064 was registered on 31 Oct 2023.

    31 Oct 2023

  • Director Appointment

    Pintu Kumar Mehta was appointed as a Director was appointed as a Director on 07 Jul 2021 & has been associated with this company since 3 years 6 months .

    07 Jul 2021

  • Director Appointment

    Guddu Kumar Jha was appointed as a Director was appointed as a Director on 07 Jul 2021 & has been associated with this company since 3 years 6 months .

    07 Jul 2021

  • Company Incorporation

    Jack Smith India Private Limited was registered on 07 Jul 2021 with Roc Shillong & aged 3 years 6 months as per MCA records.

    07 Jul 2021

Frequently asked questions

  • Jack Smith India Private Limited was incorporated on 07 Jul 2021.

  • The authorized share capital of Jack Smith India Private Limited is ₹ 1.50 M and paid-up capital is ₹ 0.15 M.

  • Currently 2 directors are associated with Jack Smith India Private Limited.

    • Pintu Kumar Mehta
    • Guddu Kumar Jha
  • As per Ministry of Corporate Affairs (Mca), the registered address of Jack Smith India Private Limited is House No. 2 Second Floor Maniram Dewan Lane, G S Road India, Gmc, Assam, 781007.

  • The corporate identification number (CIN) of Jack Smith India Private Limited is U51909AS2021PTC021557 and the company number is 021557 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Jack Smith India Private Limited has risen by 724.26%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Jack Smith India Private Limited has experienced an upsurge of 134.72%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Jack Smith India Private Limited amount to ₹ 1.00 M.

  • The most recent Balance Sheet for Jack Smith India Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development